Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 8667

BillFederalHouseIn Committee
MISSION Rx Act
About This Bill
Committee
Latest Action · May 7, 2026
Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress
119th (2025–2027)
Introduced
May 7, 2026
Cosponsors (15)
15D 0R
View PDF ↗

Summary

Highlight any text to annotate
The MISSION Rx Act would cap out-of-pocket costs for military families and veterans on prescription drugs that are part of Medicare's drug price negotiation program. Specifically, TRICARE beneficiaries and veterans would pay no more for these selected drugs than Medicare Part D patients pay under the same negotiated prices. The bill also requires federal agencies, including the Department of Veterans Affairs, to limit what they pay for these negotiated drugs to the maximum fair prices established through Medicare's negotiation program when entering into drug purchase agreements with manufacturers. These changes would take effect immediately for any drug agreements in place or created after the bill's enactment, and the price caps would remain in effect for the duration of those agreements as long as the Medicare drug price negotiation program continues.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.